Developmental funds for the next cycle are essential to our strategic plan to adopt new technology and acquire faculty expertise necessary to compliment our existing programs and advance cancer research. Moffitt proposes utilizing Developmental Funds in three categories as follows: 1) Targeted Faculty Recruitment ($200,000); 2) Pilot Projects ($100,000) and 3) Development of New Shared Resources ($100,000). During the last funding period, Moffitt benefited from developmental funds and matching institutional funds in the areas of targeted faculty recruitment and pilot projects. Moffitt invested $18.5M in support of 51 new research members over the last funding cycle, including 4 supported by Developmental Funds. Recruitment packages include a portion of salary (protected time), start-up packages, capital investments for labs, and allocation of space. Moffitt also utilized Developmental Funds with additional institutional commitment to fund pilot proposals that demonstrated a high degree of collaboration and reflected new areas of research.

Public Health Relevance

Developmental Funds play an essential role in the continued growth of the Moffitt Cancer Center by providing resources for targeted recruitment, funding innovative collaborative pilot projects and developing new shared resources to support faculty needs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA076292-17
Application #
8815024
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2016-01-31
Budget Start
2015-02-01
Budget End
2016-01-31
Support Year
17
Fiscal Year
2015
Total Cost
$235,610
Indirect Cost
$95,782
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Saltos, Andreas; Khalil, Farah; Smith, Michelle et al. (2018) Clinical associations of mucin 1 in human lung cancer and precancerous lesions. Oncotarget 9:35666-35675
Rivera, Y M; Moreno, L; Briant, K J et al. (2018) Developing Sustainable Cancer Education Programs: Training Public Health Students to Deliver Cancer 101 in Puerto Rico. J Cancer Educ 33:128-133
Maharaj, Kamira; Powers, John J; Achille, Alex et al. (2018) Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia. Blood Adv 2:3012-3024
Gjyshi, Anxhela; Dash, Sweta; Cen, Ling et al. (2018) Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine. Sci Rep 8:8291
Zhu, Genyuan; Brayer, Jason; Padron, Eric et al. (2018) OMIP-049: Analysis of Human Myelopoiesis and Myeloid Neoplasms. Cytometry A 93:982-986
Schaal, Courtney M; Bora-Singhal, Namrata; Kumar, Durairaj Mohan et al. (2018) Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer. Mol Cancer 17:149
Hampras, Shalaka S; Locke, Frederick L; Chavez, Julio C et al. (2018) Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients. Leuk Lymphoma 59:911-917
Bowman-Curci, Meghan; Quinn, Gwendolyn P; Reinecke, Joyce et al. (2018) Comparing fertility preservation resources and policies between NCCN member and non-member institutions. Support Care Cancer :
Persi, Erez; Duran-Frigola, Miquel; Damaghi, Mehdi et al. (2018) Systems analysis of intracellular pH vulnerabilities for cancer therapy. Nat Commun 9:2997
Kim, Youngchul; Pierce, Christine M; Robinson, Lary A (2018) Impact of viral presence in tumor on gene expression in non-small cell lung cancer. BMC Cancer 18:843

Showing the most recent 10 out of 1254 publications